Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fangchinoline-treated HepG2 cells

ABSTRACT: HepG2 cells were treated with 50 uM fangchinoline for 24 h. Proteomic profile of fangchinoline-treated HepG2 cells was compared with untreated cells.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Laddawan Senggunprai

PROVIDER: PXD076779 | JPOST Repository | Thu Apr 09 00:00:00 BST 2026

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20260327_Aj%20Laddawan_Proteomics%20on%20HepG2%20Cell%20Samples.xlsx	Xlsx
	OneDrive_1_3-30-2026.zip	Other
	Raw%20Agilent%20.d%20file.zip	Other

Items per page:

1 - 3 of 3

Similar Datasets

Proteomic profile of rosiglitazone-treated CCA KKU-100 cells

Project description:Project compared the proteomic profile of untreated cells and rosiglitazone-treated KKU-100 cells

2025-11-13 | PXD070682 | JPOST Repository

Identification of lactoylation on PHGDH

Project description:Sites of lactoylation were identified on both recominant human PHGDH and PHGDH in cellulo. For recombinant protein, sample was treated with 100 uM LGSH for 24 hours. For in cellulo, cells were transfected with PHGDH-mycDDK and treated with 50 uM MGO for lactoylLys identification.

2026-03-09 | PXD060533 | Pride

Temporal gene regulation of human hepatocellular carcinoma HepG2 cells treated with obacunone

Project description:Obacunone treatment slightly changes gene expression of cholesterol metabolism-associated genes in HepG2 cells Total RNA obtained from HepG2 cells treated with 100 uM obacunone for 0.5, 1, 3, 6, or 12 h was compared to that of vehicle control cells.

2014-04-29 | E-GEOD-57081 | biostudies-arrayexpress

SpiD3-treated Human OSU-CLL cells LC-MSMS

Project description:OSU-CLL cells were treated with SpiD3 (1 uM) or DMSO for 24 h.

2024-04-30 | PXD043688 | Pride

Global analysis of cancer cell responses to USP9X inhibition

Project description:Treatment of cancer cells MDA-MB-231 and MiaPaca2 with WEHI-092 (10 uM, 24 h) or FT709 (10 uM, 24 h). Sample key of raw file in ZIP folder: #1-6 MDA-MB-231 DMSO (untreated); #13-18 MDA-MB-231 FT709; #19-24 MDA-MB-231 WEHI-092; #25-30 MiaPaca2 DMSO (untreated); #37-42 MiaPaca2 FT709; #43-48 MiaPaca2 WEHI-092.

2026-04-09 | PXD074729 | Pride

Transcriptome profile of M.tb treated/untreated host cells

Project description:Transcriptome profile of M.tb treated/untreated host cells

| PRJNA517929 | ENA

A secretome profile indicative of oleate-induced proliferation of HepG2 hepatocellular carcinoma cell line

Project description:Increased fatty acid (FA) is often observed in highly proliferative tumors, contributing to promoting proliferation of tumor cells. FA affects secreted factors from tumor cells, which can modulate tumor microenvironment in favor of tumor survival. However, the secreted factors affected by the increased FA have not been systematically explored. Here, we performed comprehensive secretome profiling of oleate-treated and untreated HepG2 cells. Comparison of the secretomes identified 349 differentially secreted proteins (DSPs; 145 up-regulated and 192 down-regulated) in oleate-treated samples, compared to untreated samples. Functional enrichment and network analyses of the DSPs revealed that the 145 up-regulated secreted proteins by oleate treatment were mainly associated with cell proliferation-related processes, such as lipid metabolism, inflammatory response, and ER stress. Based on the network models of the DSPs, we selected four up-regulated secreted proteins (MIF, THBS1, PDIA3, and APOA1) that can represent such processes related to cell proliferation. Thus, our results provided a secretome profile indicative of oleate-induced proliferation of HepG2 cells.

2018-08-08 | PXD007906 | Pride

Expression data of Panc1 cells treated with romidepsin and tamoxifen

Project description:Tamoxifen enhances romidepsin-induced senescence in pancreatic cancer cells. We compared gene-expression profile among untreated control, romidepsin-treated, tamoxifen-treated, and romidepsin plus tamoxifen-treated Panc1 cells.

2021-08-21 | GSE182526 | GEO

Proteomics study on caffeine treated for 24 h

Project description:Proteomics study on the HepG2 cells which were treated with 6 doses of caffeine for 24 h

2022-01-14 | PXD030946 |

Transcriptomics study on HepG2 cells treated with different doses of caffeine for 24 h.

Project description:With the general adoption of new approach methodologies, the omic-based technologies are of particular importance for chemical hazard characterization owning to the premise that any apical endpoint change indicative of impaired health must be underpinned by some alterations at the omic level. In this work we studied cellular response to caffeine by measuring transcriptomics experiments. The HepG2 cells were treated with 6 doses of caffeine for 24 h. 1 control group was set (0 uM of coumarin). Each group has 3 biological replicates.

2023-04-26 | GSE200700 | GEO